GL1X · GenesisL1 explorer

Research workbench

Understanding the role of LEU22 variants in methotrexate resistance: comparison of wild-type and LEU22ARG variant mouse and human dihydrofolate reductase

Analyse Understanding the role of LEU22 variants in methotrexate resistance: comparison… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1U70
Type
protein
Length
186 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dihydrofolate reductase
EC
1.5.1.3
UniProt
P00375
Ligands
MTX, NDP
Pockets
2 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 21% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADihydrofolate reductase (EC 1.5.1.3)protein18621% helix, 32% strandP00375

Ligands and binding sites

  • MTX · Methotrexate · ligand · chains A
  • NDP · Nadph dihydro-nicotinamide-adenine-dinucleotide phosphate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15010.740.8250MTX, NDP
2540.330.7816empty

Compared structures

  • 1U70 · Understanding the Role of Leu22 Variants in Methotrexate Resistance: Comparison of… · the same entry in another collection · chain A against A, TM-score 1.00
  • P00375 · AlphaFold monomer V2.0 prediction for dihydrofolate reductase (P00375) · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.